Long noncoding RNA MALAT1 promotes aggressive pancreatic cancer proliferation and metastasis via the stimulation of autophagy

Molecular Cancer Therapeutics

Volumn 15, Issue 9, 2016, Pages 2232-2243

  Li, Le ^a   Chen, Hua ^a   Gao, Yue ^b   Wang, Yong Wei ^a   Zhang, Guang Quan ^a   Pan, Shang Ha ^a   Ji, Liang ^a   Kong, Rui ^a   Wang, Gang ^a   Jia, Yue Hui ^c   Bai, Xue Wei ^a   Sun, Bei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b LERNER RESEARCH INSTITUTE   (United States)

^c QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ELAV LIKE PROTEIN 1; LONG UNTRANSLATED RNA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; PROTEIN P62; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; MALAT1 LONG NON-CODING RNA, HUMAN; POLYADENYLIC ACID BINDING PROTEIN; TIA1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER THERAPY; CELL PROLIFERATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS METASTASIS; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA BINDING; RNA ISOLATION; TUMOR GROWTH; TUMOR MODEL; UPREGULATION; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METASTASIS; MORTALITY; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; AUTOPHAGY; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ELAV-LIKE PROTEIN 1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MICE; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; POLY(A)-BINDING PROTEINS; PROGNOSIS; RNA INTERFERENCE; RNA, LONG NONCODING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84990877455     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-16-0008     Document Type: Article

References (47)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
2. Hidalgo M. Pancreatic cancer. N Engl J Med 2010;362:1605-17.
3. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009;23:1494-504.
4. Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia R, et al. Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther 2015;14:268-77.
5. Ge D, Han L, Huang S, Peng N, Wang P, Jiang Z, et al. Identification of a novel MTOR activator and discovery of a competing endogenous RNA regulating autophagy in vascular endothelial cells. Autophagy 2014;10:957-71.
6. Zhang ZZ, Shen ZY, Shen YY, Zhao EH, Wang M, Wang CJ, et al. HOTAIR long noncoding RNA promotes gastric cancer metastasis through suppression of poly r (C)-binding protein (PCBP) 1. Mol Cancer Ther 2015;14:1162-70.
7. Gutschner T, Hämmerle M, Eissmann M, Hsu J, Kim Y, Hung G, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2013;73:1180-89.
8. Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, Monga SP, et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 2006;44:1012-24.
9. Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F, et al. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol 2013;190:2278-87.
10. Jiao F, Hu H, Yuan C, Wang L, Jiang W, Jin Z, et al. Elevated expression level of long noncoding RNA MALAT-1 facilitates cell growth, migration and invasion in pancreatic cancer. Oncol Rep 2014;32:2485-92.
11. Pang EJ, Yang R, Fu XB, Liu YF. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumor Biol 2015;36:2403-7.
12. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012;8:445-544.
13. Galluzzi L, Pietrocola F, Levine B, Kroemer G. Metabolic control of autophagy. Cell 2014;159:1263-76.
14. Balic A, Sørensen MD, Trabulo SM, Sainz B Jr, Cioffi M, Vieira CR, et al. Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and Hedgehog signaling. Mol Cancer Ther 2014;13:1758-71.
15. Marchand B, Arsenault D, Raymond-Fleury A, Boisvert FM, Boucher MJ. Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells. J Biol Chem 2015;290:5592-605.
16. Rosenfeldt MT, O'Prey J, Morton JP, Nixon C, MacKay G, Mrowinska A, et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature 2013;504:296-300.
17. Wang K, Liu CY, Zhou LY, Wang JX, Wang M, Zhao B, et al. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat Commun 2015;6:6779.
18. Jia G, Kong R, Ma ZB, Han B, Wang YW, Pan SH, et al. The activation of c-Jun. NH2-terminal kinase is required for dihydroartemisinininduced autophagy in pancreatic cancer cells. J Exp Clin Cancer Res 2014;33:8.
19. Lv JC, Wang G, Pan SH, Bai XW, Sun B. Lycopene protects pancreatic acinar cells against severe acute pancreatitis by abating the oxidative stress through JNK pathway. Free Radic Res 2015;49:151-63.
20. Cheng ZX, Sun B, Wang SJ, Gao Y, Zhang YM, Zhou HX, et al. Nuclear Factor-kB-dependent epithelial to mesenchymal transition induced by HIF-1a activation in pancreatic cancer cells under hypoxic conditions. PLoS One 2011;6:e23752.
21. Wang Y, Zhou Y, Zhou H, Jia G, Liu J, Han B, et al. Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells. PLoS One 2012;7:e43826.
22. Wang Y, Zhou Y, Jia G, Han B, Liu J, Teng Y, et al. Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: involvement of NF-kB signaling pathway. Biochem Pharmacol 2014;88:322-33.
23. Kong R, Sun B, Jiang H, Pan S, Chen H, Wang S, et al. Downregulation of nuclearfactor-kappaB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer. Cancer Lett 2010;291:90-8.
24. Ko YH, Cho YS, Won HS, Jeon EK, An HJ, Hong SU, et al. Prognostic significance of autophagy-related protein expression in resected pancreatic ductal adenocarcinoma. Pancreas 2013;42:829-35.
25. Yang A, Kimmelman AC. Inhibition of autophagy attenuates pancreatic cancer growth independent of TP53/TRP53 status. Autophagy 2014;10:1683-4.
26. White E, Mehnert JM, Chan CS. Autophagy, metabolism, and cancer. Clin Cancer Res 2015;21:5037-46.
27. Antonucci L, Fagman JB, Kim JY, Todoric J, Gukovsky I, Mackey M, et al. Basal autophagy maintains pancreatic acinar cell homeostasis and protein synthesis and prevents ER stress. Proc Natl Acad Sci U S A 2015;112:e6166-74.
28. Ling J, Kang Y, Zhao R, Xia Q, Lee DF, Chang Z, et al. Kras G12D-induced IKK2/b/NF-kB activation by IL-1a and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 2012;21:105-20.
29. Sánchez-Jiménez C, Ludeña MD, Izquierdo JM. T-cell intracellular antigens function as tumor suppressor genes. Cell Death Dis 2015;6:e1669.
30. Sánchez-Jiménez C, Izquierdo JM. T-cell intracellular antigen (TIA)-proteins deficiency in murine embryonic fibroblasts alters cell cycle progression and induces autophagy. PloS One 2013;8:e75127.
31. Pullmann R Jr, Kim HH, Abdelmohsen K, Lal A, Martindale JL, Yang X, et al. Analysis of turnover and translation regulatory RNA-binding protein expression through binding to cognate mRNAs. Mol Cell Biol 2007;27:6265-78.
32. Katsanou V, Papadaki O, Milatos S, Blackshear PJ, Anderson P, Kollias G, et al. HuR as a negative posttranscriptional modulator in inflammation. Mol Cell 2005;19:777-89.
33. Lock R, Roy S, Kenific CM, Su JS, Salas E, Ronen SM, et al. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol Biol Cell 2011;22:165-78.
34. Li J, Yang B, Zhou Q, Wu Y, Shang D, Guo Y, et al. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelialmesenchymal transition. Carcinogenesis 2013;34:1343-51.
35. Che W, Dong Y, Quan HB. RANKL inhibits cell proliferation by regulating MALAT1 expression in a human osteoblastic cell line hFOB 1.19. Cell Mol Biol (Noisy-le-grand) 2015;61:7-14.
36. Vassallo I, Zinn P, Lai M, Rajakannu P, Hamou MF, Hegi ME. WIF1 reexpression in glioblastoma inhibits migration through attenuation of noncanonical WNT signaling by downregulating the lncRNA MALAT1. Oncogene 2016;35:12-21.
37. Hirata H, Hinoda Y, Shahryari V, Deng G, Nakajima K, Tabatabai ZL, et al. Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205. Cancer Res 2015;75:1322-31.
38. Yang MH, Hu ZY, Xu C, Xie LY, Wang XY, Chen SY, et al. MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9. Biochim Biophys Acta 2015;1852:166-74.
39. Fu X, Liu Y, Zhuang C, Liu L, Cai Z, Huang W. Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and. 5637. Mol Biosyst 2015;11:1285-9.
40. Wilusz JE, Freier SM, Spector DL. 30 end processing of a long nuclearretained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell 2008;135:919-32.
41. Kuma A, Matsui M, Mizushima N. LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy: caution in the interpretation of LC3 localization. Autophagy 2007;3:323-8.
42. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 2003;100:15077-82.
43. Nishida Y, Arakawa S, Fujitani K, Yamaguchi H, Mizuta T, Kanaseki T, et al. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 2009;461:654-8.
44. Dominguez-Bautista JA, Klinkenberg M, Brehm N. Loss of lysosomeassociated membrane protein 3 (LAMP3) enhances cellular vulnerability against proteasomal inhibition. Eur J Cell Biol 2015;94:148-61.
45. Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 1991;67:629-39.
46. Ray D, Kazan H, Cook KB, Weirauch MT, Najafabadi HS, Li X, et al. A compendium of RNA-binding motifs for decoding gene regulation. Nature 2013;499:172-7.
47. Sánchez-Jiménez C, Izquierdo JM. T-cell intracellular antigens in health and disease. Cell Cycle 2015;14:2033-43.